Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianqing Granules for Common Cold (Wind-Heat Pattern)
CTR20220537Phase 2Completed
- Sponsor
- Hunan Huana Pharmaceuticals
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nasopharyngitis comparing Qianqing Granules with Placebo (2 arms). Primary endpoint: Change in disease treatment and disease-related symptom and sign scores from baseline. Started Mar 2022; status: completed.
02
Drugs
qianqing granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20220537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220537.